Copy

Invest to End TB. Save Lives

"In 2020, spending on TB amounted to less than half (41%) of the global target. Closing this funding gap for TB, which has been exacerbated due to the COVID-19 pandemic, will take nothing less than a transformation in our approach to global advocacy, domestic resource mobilization, and improvements in efficiency." 
 
— MSH’s Dr. Zina Jarrah, Technical Director for the USAID Health Systems for TB Project

The COVID-19 pandemic has reversed years of progress made in the fight to end TB. 

Between 2020 and 2021, more than half of all countries reported disrupted TB services, and for the first time in more than a decade, deaths from TB increased in 2020. Challenges with providing and accessing essential TB services have meant that many people with TB were not diagnosed in 2020, and WHO estimates a global decline of 18% in the number of people newly diagnosed with TB, back to the levels measured in 2012. 

While fighting COVID-19, our staff has remained committed to sustaining essential TB services and to bringing diagnostic, preventive, and treatment services to people at high risk for TB. We have run ad campaigns in Ethiopia to educate families on the importance of preventative TB treatment, strengthened stock management systems for TB medicines in Bangladesh, and helped governments use key TB resources more efficiently. 

Every day more than 4,000 people die and 27,000 people become ill with TB. We must sound the alarm that TB is the single largest infectious killer and respond appropriately to what TB truly is: a global public health emergency. MSH is joining partners worldwide to urge the international community, donors, and governments to increase funding and political support for TB control efforts. This is the time to invest to save the lives of the most vulnerable populations.


Sincerely, 

Dr. Pedro Suarez
Global TB Lead at MSH

Strong Health Systems. Greater Health Impact
View in browser  |  Share with a friend  |  Subscribe
Copyright © 2022 Management Sciences for Health, All rights reserved.
Follow us on Twitter Follow us on Twitter
Join us on LinkedIn Join us on LinkedIn
Medium Medium
Like us on Facebook Like us on Facebook
Watch us on YouTube Watch us on YouTube
Explore our website Explore our website